OTTAWA — Prime Minister Justin Trudeau on Tuesday announced an investment of nearly Can$200 million (US$166 million) in an Ontario facility that will be capable of producing millions of mRNA vaccines like the shots being used to fight the coronavirus pandemic.
The investment in Resilience Biotechnologies, the Canadian subsidiary of US firm National Resilience, should help Canada become less reliant on foreign-made vaccines, as it has been during the current Covid-19 crisis.
The expansion of the Resilience Biotech plant in Mississauga is “essential to be prepared to face any future health crisis,” Trudeau told a news conference.
Canada currently has no domestic vaccine prod…
Keep on reading: Dependent on foreign jabs, Canada invests in vaccine production